DSwiss Inc., a biotech nutraceutical firm specializing in premium healthcare, skincare, and personal care solutions, has released its annual Form 10-K report. The report highlights the company's substantial financial growth, strategic business initiatives, and the challenges it faces in the competitive health and beauty industry.
Financial Highlights
- Revenue: $3.11 million, representing a 111.8% increase from the previous year, mainly from OEM/ODM sales of Nutraceutical and Skincare Supplies.
- Gross Profit: $0.62 million, an increase from $0.36 million in the previous year, despite a decrease in gross margin from 24.44% to 20.02%.
- Net Income: $0.02 million, compared to a net loss of $0.05 million in the previous year, driven by increased revenue.
- Net profit/(loss) per share- Basic and diluted: $0.0001, reflecting the company's return to profitability.
Business Highlights
- Business Overview: DSwiss, Inc. is a biotech nutraceutical firm specializing in premium healthcare, skincare, and personal care solutions. The company operates through its subsidiaries, focusing on the supply of high-quality health and beauty products, including weight management beverages, anti-aging solutions, and immune system enhancers.
- Geographical Performance: DSwiss has expanded its market presence across Malaysia, Singapore, Indonesia, Hong Kong, Australia, Taiwan, Macau, and China. The company is actively exploring new global markets, with a strategic focus on re-entering key international markets such as China, the United States, Singapore, and others.
- New Product Launches: The company has developed a comprehensive pet wellness supplement designed to support skin, joint, and immune health in pets, reflecting its expansion into the pet-care sector.
- Commitment to Quality and Innovation: DSwiss emphasizes the use of premium natural active ingredients and adheres to the regulations set by the Ministry of Health Malaysia. The company integrates customer feedback to drive innovation and excellence in its product offerings.
- Comprehensive OEM & ODM Solutions: DSwiss provides end-to-end solutions, including strategic business consultancy, market trend analysis, and marketing support, to meet the unique needs of its clients in the health and beauty market.
- Future Outlook: The company plans to enhance its marketing efforts through targeted social media campaigns and e-commerce platforms to increase product visibility and strengthen brand awareness. DSwiss aims to expand its workforce by 50% by the end of 2025 and establish internship partnerships with top universities in Malaysia.
- Merger & Acquisition Strategy: DSwiss is pursuing strategic mergers and acquisitions to drive growth and unlock synergies across key sectors, including healthcare, biotechnology, beauty, and wellness.
- Regulatory Compliance: The company ensures compliance with the Drug Control Authority, Ministry of Health Malaysia, for products that meet the definition of functional food and cosmetics.
Strategic Initiatives
- Market Expansion: DSwiss, Inc. aims to expand its market presence by penetrating Southeast Asian markets through the recruitment of distributors and leveraging social media platforms like Facebook and Instagram. The company is also focused on forming strategic partnerships with local companies in various countries to stock and promote its products, facilitating global expansion.
- Capital Management: As of December 31, 2024, DSwiss, Inc. had a working capital surplus of $13,645, with cash and cash equivalents amounting to $397,476. The company generated net cash from operating activities of $182,699, primarily due to increased other payables and accrued liabilities. It also used $105,258 in investing activities for the purchase of plant and equipment and generated $68,306 from financing activities, mainly through finance lease additions and repayments. The company did not repurchase any shares of its common stock during the fiscal year ended December 31, 2024, and has no current plans to pay dividends.
- Future Outlook: DSwiss, Inc. plans to continue expanding its operations and brand awareness primarily through social media marketing strategies. The company is considering acquiring additional funding through equity or debt financing, bank loans, or revolving credit facilities to support its operations and further expansion. The company also intends to maintain its focus on strategic partnerships to accelerate global expansion.
Challenges and Risks
- Competitive Industry: DSwiss, Inc. operates in the highly competitive health and beauty industry, which is subject to rapid changes in consumer preferences and technological advancements. The company faces challenges in maintaining its market position and expanding its global reach, particularly in new markets such as Myanmar, Macau, Vietnam, and Cambodia.
- Social Media Dependence: The company's reliance on social media for marketing and customer engagement presents both opportunities and risks, as changes in social media algorithms or policies could impact its ability to reach customers effectively.
- Regulatory Risks: The company's operations in multiple jurisdictions expose it to various regulatory risks, including compliance with local health and safety standards, import/export regulations, and intellectual property laws. The company's expansion into new markets may also introduce additional regulatory challenges and potential barriers to entry.
- Financial Risks: DSwiss is exposed to market risks, including fluctuations in foreign currency exchange rates, which could affect its financial performance. The company operates in multiple countries, and changes in exchange rates between the US dollar, Malaysian Ringgit, and Hong Kong Dollar could impact its revenue and profitability. Additionally, the company faces risks related to changes in consumer demand and preferences, which could affect sales of its nutraceutical and skincare products.
SEC Filing: